| [2] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| [3] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1): 7-34.
|
| [4] |
Patel HD, Karam JA, Allaf ME. Surgical management of advanced kidney cancer: the role of cytoreductive nephrectomy and lymphadenectomy[J]. J Clin Oncol, 2018, 36(36): 3601-3607.
|
| [5] |
Dekernion JB, Ramming KP, Smith RB. The Natural History of Metastatic Renal Cell Carcinoma: A Computer Analysis[J]. J Urol, 1978, 120(2): 148-152.
|
| [6] |
Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer[J]. N Engl J Med, 2001, 345(23): 1655-1659.
|
| [7] |
Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial[J].Lancet, 2001, 358(9286): 966-970.
|
| [8] |
Flanigan RC, Mickisch G, Sylvester R, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis[J].J Urol, 2004, 171(3): 1071-1076.
|
| [9] |
Ljungberg B, Hanbury DC, Kuczyk MA, et al. Renal cell carcinoma guideline[J]. Eur Urol, 2007, 51(6): 1502-1510.
|
| [10] |
Bex A, Albiges L, Ljungberg B, et al. Updated European Association of Urology guidelines for cytoreductive nephrectomy in patients with synchronous metastatic clear-cell renal cell carcinoma[J]. Eur Urol, 2018, 74(6): 805-809.
|
| [11] |
Bhindi B, Abel EJ, Albiges L, et al. Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: an individualized approach to metastatic renal cell carcinoma[J]. Eur Urol, 2019, 75(1): 111-128.
|
| [12] |
Conti SL, Thomas IC, Hagedorn JC, et al. Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era[J].Int J Cancer, 2014, 134(9): 2245-2252.
|
| [13] |
Heng DY, Wells JC, Rini BI, et al. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium[J]. Eur Urol, 2014, 66(4): 704-710.
|
| [14] |
Heng DY, Xie W, Regan MM, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results froma large, multicenter study[J]. J Clin Oncol, 2009, 27(34): 5794-5799.
|
| [15] |
Hanna N, Sun M, Meyer CP, et al. Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a national cancer data base study[J].J Clin Oncol, 2016, 34(27): 3267-3275.
|
| [16] |
Mejean A, Ravaud A, Thezenas S, et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma[J]. N Engl J Med, 2018, 379(5): 417-427.
|
| [17] |
Bex A, Ljungberg B, van Poppel H, et al. The role of cytoreductive nephrectomy: european association of urology recommendations in 2016[J]. Eur Urol, 2016, 70(6): 901-905.
|
| [18] |
Arora S, Sood A, Dalela D, et al. Cytoreductive nephrectomy: assessing the generalizability of the carmena trial to real-world national cancer data base cases[J]. Eur Urol, 2019, 75(2): 352-353.
|
| [19] |
Motzer RJ, Russo P. Cytoreductive nephrectomy - patient selection is key[J]. N Engl J Med, 2018, 379(5): 481-482.
|
| [20] |
Capitanio U, Larcher A, Montorsi F. Cytoreductive nephrectomy is dead, long live cytoreductive nephrectomy[J]. BJU Int, 2019, 124(1): 6-7.
|
| [21] |
Trinh QD, Bianchi M, Hansen J, et al. In-hospital mortality and failure to rescue after cytoreductive nephrectomy[J].Eur Urol, 2013, 63(6): 1107-1114.
|
| [22] |
Graham J, Wells C, Donskov F, et al. Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium (IMDC) [J]. J Clinical Oncol, 2018, 36(6_suppl): 581-581.
|
| [1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| [23] |
Daugherty M, Daugherty E, Jacob J, et al. Renal cell carcinoma and brain metastasis: Questioning the dogma of role for cytoreductive nephrectomy[J]. Urol Oncol, 2019, 37(3): 182.e189-182.e115.
|